Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this fourth of 6 sections of the guidelines of care for psoriasis, we discuss the use of traditional systemic medications for the treatment of patients with psoriasis. Treatment should be tailored to meet individual patients' needs. We will discuss in detail the efficacy and safety, and offer recommendations for the use of the 3 most commonly used, and approved, traditional systemic agents: methotrexate, cyclosporine, and acitretin. We will also briefly discuss the available data for the use of azathioprine, fumaric acid esters, hydroxyurea, leflunomide, mycophenolate mofetil, sulfasalazine, tacrolimus, and 6-thioguanine in psoriasis.
Menter
Alan
A
Baylor University Medical Center, Dallas, Texas, USA.
Korman
Neil J
NJ
Elmets
Craig A
CA
Feldman
Steven R
SR
Gelfand
Joel M
JM
Gordon
Kenneth B
KB
Gottlieb
Alice B
AB
Koo
John Y M
JY
Lebwohl
Mark
M
Lim
Henry W
HW
Van Voorhees
Abby S
AS
Beutner
Karl R
KR
Bhushan
Reva
R
D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003880:Dermatology / Q000592:standards; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011701:PUVA Therapy; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000188:drug therapy
D003879:Dermatologic Agents; D007166:Immunosuppressive Agents